SUBSCRIBERS
Shanghai Pharma buys Cardinal Health's China business for US$557m
Published Wed, Nov 15, 2017 · 09:50 PM
Hong Kong
SHANGHAI Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc's China drug distribution business for US$557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide.
The deal will also help Shanghai Pharma, China's third largest drug distributor, become a leading importe…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Billionaires selling cheap stuff get richer from inflation pain
Amazon to push cashierless shopping tech into more third-party stores, while backing off itself
Japan’s Uniqlo opens Rome store as part of European expansion
Abbott beats quarterly profit estimates on strong medical device sales
Adidas shares surpass two-year high as 'terrace' sneaker trend boosts brand heat
LVMH’s first quarter sales growth slips to 3% on luxury slowdown